|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–63. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang X, Shi X, Huang D, Li B, Lin N, Pan
W, Yan X, Li H, Hao Q and Ye Z: Mutational characteristics of bone
metastasis of lung cancer. Ann Palliat Med. 10:8818–8826. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sugiura H, Yamada K, Sugiura T, Hida T and
Mitsudomi T: Predictors of survival in patients with bone
metastasis of lung cancer. Clin Orthop Relat Res. 466:729–736.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hernandez RK, Wade SW, Reich A, Pirolli M,
Liede A and Lyman GH: Incidence of bone metastases in patients with
solid tumors: Analysis of oncology electronic medical records in
the United States. BMC Cancer. 18:442018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jimenez-Andrade JM, Mantyh WG, Bloom AP,
Ferng AS, Geffre CP and Mantyh PW: Bone cancer pain. Ann N Y Acad
Sci. 1198:173–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu S, Pan Y, Mao Y, Chen Y and He Y:
Current progress and mechanisms of bone metastasis in lung cancer:
A narrative review. Transl Lung Cancer Res. 10:439–451. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:6243s–6249s. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hoda MA, Rozsas A, Lang E, Klikovits T,
Lohinai Z, Torok S, Berta J, Bendek M, Berger W, Hegedus B, et al:
High circulating activin A level is associated with tumor
progression and predicts poor prognosis in lung adenocarcinoma.
Oncotarget. 7:13388–13399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fornetti J, Welm AL and Stewart SA:
Understanding the bone in cancer metastasis. J Bone Miner Res.
33:2099–2113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kommalapati A, Tella SH, Esquivel MA and
Correa R: Evaluation and management of skeletal disease in cancer
care. Crit Rev Oncol Hematol. 120:217–226. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Sullivan GJ, Carty FL and Cronin CG:
Imaging of bone metastasis: An update. World J Radiol. 7:202–211.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Çayir D, Bozkurt M, Gültekin SS and
Karaçalioğlu AÖ: Earlier phases of bone scintigraphy can better
delineate the extent of soft tissue involvement of bone metastasis.
Clin Nucl Med. 43:854–856. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bozzo A, Deng J, Abbas U, Bhasin R, Deodat
M, Wariach S, Sanger S, Axelrod D, Masrouha K, Turcotte R, et al:
Which bone-modifying agent is associated with better outcomes in
patients with skeletal metastases from lung cancer? A systematic
review and network meta-analysis. Clin Orthop Relat Res.
479:2047–2057. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huskisson EC: Measurement of pain. Lancet.
2:1127–1131. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nam H, Lim JS, Kim JS, Lee KJ, Koo DL and
Lee C: Sleep perception in obstructive sleep apnea: A study using
polysomnography and the multiple sleep latency test. J Clin Neurol.
12:230–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jadad AR and Browman GP: The WHO analgesic
ladder for cancer pain management. Stepping up the quality of its
evaluation. JAMA. 274:1870–1873. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chai X, Yinwang E, Wang Z, Wang Z, Xue Y,
Li B, Zhou H, Zhang W, Wang S, Zhang Y, et al: Predictive and
prognostic biomarkers for lung cancer bone metastasis and their
therapeutic value. Front Oncol. 11:6927882021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ursavas A, Karadag M, Uzaslan E, Rodoplu
E, Demirdögen E, Burgazlioglu B and Gozu RO: Can clinical factors
be determinants of bone metastases in non-small cell lung cancer?
Ann Thorac Med. 2:9–13. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Q, Wang W, Cheng D, Wang Y, Han Y,
Huang J and Peng X: Non-coding RNA in exosomes: Regulating bone
metastasis of lung cancer and its clinical application prospect.
Transl Oncol. 46:1020022024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arakil N, Akhund SA, Elaasser B and
Mohammad KS: Intersecting paths: Unraveling the complex journey of
cancer to bone metastasis. Biomedicines. 12:10752024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maroni P, Gomarasca M and Lombardi G: Long
non-coding RNAs in bone metastasis: Progresses and perspectives as
potential diagnostic and prognostic biomarkers. Front Endocrinol
(Lausanne). 14:11564942023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lv T, Li Z, Wang D, Guo X, Zhang X, Cao J
and Wang Z: Role of exosomes in prostate cancer bone metastasis.
Arch Biochem Biophys. 748:1097842023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu S, Hu T, Zhou C, Wang M, Jiang J, Wang
Y and Wang C: The ratio of lymph node eluate/serum cytokeratin 21-1
is a potential predictor of lymph node metastasis in lung
adenocarcinoma. J Thorac Dis. 16:5709–5717. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Dai S, Liu Z, He L, Zhu L, Qin Z,
Fan H, Fang F, Xie Y and Peng X: Serum tumor markers and outcomes
in lung cancer patients with brain metastases: A retrospective
longitudinal cohort study. Transl Lung Cancer Res. 13:2282–2295.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu M and Wang P: A comparative study of
ProGRP and CEA as serological markers in small cell lung cancer
treatment. Discov Oncol. 15:4852024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Passaro A, Al Bakir M, Hamilton EG, Diehn
M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C and
Peters S: Cancer biomarkers: Emerging trends and clinical
implications for personalized treatment. Cell. 187:1617–1635. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laganà M, Gurizzan C, Roca E, Cortinovis
D, Signorelli D, Pagani F, Bettini A, Bonomi L, Rinaldi S, Berardi
R, et al: High prevalence and early occurrence of skeletal
complications in EGFR mutated NSCLC patients with bone metastases.
Front Oncol. 10:5888622020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Zheng Z, Wang L, Han L, Du Y, Zhang
X, Liu X and Xie J: Association of mutation profiles with
metastasis in patients with non-small cell lung cancer. Front
Oncol. 14:14515762024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Knapp BJ, Devarakonda S and Govindan R:
Bone metastases in non-small cell lung cancer: A narrative review.
J Thorac Dis. 14:1696–1712. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang C, Wu Q, Yang H, Zhang H, Liu C,
Yang B and Hu Q: Ferroptosis-related gene signature for predicting
prognosis and identifying potential therapeutic drug in EGFR
wild-type lung adenocarcinoma. Commun Biol. 7:14162024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li N, Bian Z, Cong M and Liu Y: Survival
outcomes of patients with epidermal growth factor receptor
mutations in non-small cell lung cancer with leptomeningeal
metastasis. Front Oncol. 11:7235622022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Passaro A, Jänne PA, Mok T and Peters S:
Overcoming therapy resistance in EGFR-mutant lung cancer. Nat
Cancer. 2:377–391. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tabei Y and Nakajima Y: IL-1β-activated
PI3K/AKT and MEK/ERK pathways coordinately promote induction of
partial epithelial-mesenchymal transition. Cell Commun Signal.
22:3922024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Yang W, Han X, Qiao Y, Wang H,
Chen T, Li T and Ou WB: Knockdown of HE4 suppresses tumor growth
and invasiveness in lung adenocarcinoma through regulation of EGFR
signaling. Oncol Res. 32:1119–1128. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao A and Wang H: Targeting
tumour-osteoclast interactions: A trigger-explosion system to
combat bone metastasis. Biomater Transl. 5:328–330. 2024.PubMed/NCBI
|
|
36
|
De Felice F, Piccioli A, Musio D and
Tombolini V: The role of radiation therapy in bone metastases
management. Oncotarget. 8:25691–25699. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hong S, Youk T, Lee SJ, Kim KM and Vajdic
CM: Bone metastasis and skeletal-related events in patients with
solid cancer: A Korean nationwide health insurance database study.
PLoS One. 15:e02349272020. View Article : Google Scholar : PubMed/NCBI
|
